Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CECO +6.8% (updates 2026 outlook following Thermon acquisition) SJM +6%, ASX +2.8% (reports May revs), ODC +1.9%,
Other news:
- NUVL +38.9% (Nuvalent to be acquired by GSK for $124 per share in cash)
- APLD +10.9% (signs 210 MW lease at Delta Forge 2)
- FCEL +9.8% (files mixed securities shelf offering)
- SPTX +4.3% (reports multiple-ascending dose data from Phase 1 Proof-of-Concept Trial of GlyphAgo in healthy volunteers)
- SRE +4% (SRE unit, Qualcomm and UC San Diego launch edge AI collaboration)
- TNGX +3.7% (stock offering)
- SIRI +3.5% (to join S&P MidCap 400)
- QCOM +2.7% (SRE unit, Qualcomm and UC San Diego launch edge AI collaboration)
- SVRA +2.6% (CFO to step down; COO to assume additional role of CFO)
- SATL +2.3% (Satellogic and Rick Dunn mutually agreed that Mr. Dunn will step down as the Company's Chief Financial Officer at the conclusion of a transition period agreed between Mr. Dunn and the Company)
- NIO +1.7% (states U.S. CMC designation will not affect operations)
- PONY +1.6% (launches Luxembourg autonomous mobility pilot with Bolt and Stellantis)
- DBVT +1.4% (to present new positive data from VITESSE Study and preview recently initiated THRIVE Study)
- BKD +1.3% (reports May occupancy)
- TFX +1.3% (Four-Year BIOMAG-I study results presented at EuroPCR confirm long-term safety and sustained performance of the Freesolve resorbable magnesium scaffold)
- BIDU +1.2% (states U.S. CMC designation will not affect operations)
- ZLAB +1% (receives China approval for TIVDAK in cervical cancer)